Dr Boreham’s Crucible: Will ditching its baggage help this pancreatic cancer-targeting outfit soar?
The targeted radiation oncology outfit Oncosil Medical (ASX:OSL) has the common shortcoming of falling way behind its clinical and commercialisation targets. For instance, the company promised European Union approval in 2013 and finally won this assent in …